Get the Stockscreener App
3.07
2.23%
-0.07
Clearmind Medicine Inc stock is traded at $3.07, with a volume of 1.28M.
It is down -2.23% in the last 24 hours and down -19.23% over the past month.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
See More
Previous Close:
$3.14
Open:
$3.15
24h Volume:
1.28M
Relative Volume:
0.65
Market Cap:
$4.56M
Revenue:
-
Net Income/Loss:
$-6.64M
P/E Ratio:
-0.0171
EPS:
-179.3009
Net Cash Flow:
$-5.60M
1W Performance:
-8.08%
1M Performance:
-19.23%
6M Performance:
-88.24%
1Y Performance:
-99.11%
1-Day Range:
$2.94
$3.44
1-Week Range:
$2.92
$3.55
52-Week Range:
$2.10
$524.00
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
3.07 | 4.56M | 0 | -6.64M | -5.60M | -179.30 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clearmind Medicine Inc Stock (CMND) Latest News
HRT Financial LP trims Clearmind Medicine (CMND) stake with 22,139-share sale - Stock Titan
Clearmind Medicine receives U.S. patent for binge behavior treatment - Investing.com
Clearmind Medicine Inc Share PriceCMND, RNS News, Articles, Quotes, & Charts (NASDAQ:CMND) - Proactive financial news
symbol__ Stock Quote Price and Forecast - CNN
Insider Sell: Financial Hrt Reduces Stake in Clearmind Medicine Inc (CMND) - GuruFocus
Clearmind Medicine Inc (CMND) Institutional Confidence - TradingKey
Clearmind Medicine Inc (CMND) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clearmind Medicine (CMND) holder HRT Financial LP sells 3,183 shares - Stock Titan
Clearmind Medicine Inc (CMND) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clearmind Medicine Inc (CMND) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Clearmind Medicine Inc (CMND) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clearmind Medicine Inc (CMND) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clearmind Medicine Inc (CMND) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clearmind completes dosing for phase I/II alcohol disorder trial By Investing.com - Investing.com South Africa
Clearmind Medicine finishes dosing 24 trial participants - grafa.com
HRT Financial LP trims Clearmind Medicine (CMND) stake with 2,102-share sale - Stock Titan
Clearmind Medicine Completes Dosing For Part A Of Its Of FDA-Regulated Phase I/Ii Clinical Trial - TradingView
Experimental alcohol addiction drug completes first-stage testing - Stock Titan
Clearmind Medicine Inc (CMND) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearmind Medicine Inc (CMND) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cash per share of Clearmind Medicine Inc. – FWB:CWY0 - TradingView
Tangible book value per share of Clearmind Medicine Inc. – FWB:CWY0 - TradingView
HRT Financial LP reports 101,951 CMND shares as ten percent owner - Stock Titan
Clearmind Medicine Jumps 24.1% as Traders React to Fresh CMND-100 Updates and Upcoming June 10 Webinar - Moomoo
Clearmind Medicine Company Profile & Introduction - Moomoo
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Clearmind Medicine Inc. - MLQ.ai
Clearmind Medicine jumps 24.1% as traders react to fresh CMND-100 updates and upcoming June 10 webinar - Quiver Quantitative
CMND Stock Jumps As Clearmind Wins Key Trial, IP Milestones - StocksToTrade
CMND Stock Jumps As Clearmind Advances Trials And Expands IP - timothysykes.com
$Clearmind Medicine (CMND.US)$ - Moomoo
Clearmind Medicine to Present CMND-100 Clinical Trial Data on June 5, 2026 - geneonline.com
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on 'Inside MEAI” Webinar - The Manila Times
Clearmind Medicine Inc. to Host Live Webinar on MEAI and Alcohol Use Disorder with Yale and Johns Hopkins on June 10, 2026 - Quiver Quantitative
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar - marketscreener.com
Clearmind Medicine Shares On The Move With Cash Question Looming - Bez Kabli
CMND News | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why Did CMND Stock Jump 40% Today? - Stocktwits
CMND Technical Analysis | Trend, Signals & Chart Patterns | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Sahm
Clearmind Medicine (CMND) Revenue BreakdownMain Composition - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Clearmind announces Japanese patent application for MEAI depression treatment By Investing.com - Investing.com South Africa
Clearmind announces Japanese patent application for MEAI depression treatment - Investing.com UK
CMND Stock Jumps As Clearmind Advances Trials And IP Push - StocksToTrade
CMND Stock Spikes As Clearmind Advances Johns Hopkins Trial - timothysykes.com
Clearmind Medicine stock surges 95% on Japan patent filing By Investing.com - Investing.com Canada
Clearmind Medicine stock surges 95% on Japan patent filing - Investing.com
Clearmind Medicine Inc. Announces Publication of Japanese Patent Application for MEAI in Depression Treatment - Quiver Quantitative
Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment - The Manila Times
Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clearmind Medicine Inc Stock (CMND) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Jun 15 '26 |
Sale |
3.32 |
3,183 |
10,568 |
103,492 |
| HRT FINANCIAL LP | 10% Owner |
Jun 12 '26 |
Sale |
3.36 |
2,102 |
7,063 |
106,675 |
| HRT FINANCIAL LP | 10% Owner |
Jun 10 '26 |
Buy |
0.15 |
2,159,052 |
330,335 |
2,063,266 |
| HRT FINANCIAL LP | 10% Owner |
Jun 11 '26 |
Sale |
0.12 |
225,191 |
27,698 |
1,838,075 |
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):